2025-04-30 11:12:57

Most Hong Kong-listed biotech stocks strengthened, with CanSino Biologics (06185.HK) rising more than 10%, BeiGene (06160.HK) rising more than 6%, InnoCare Pharma (09969.HK) rising more than 4%, and Tiger Pharmaceuticals (03347.HK) rising more than 3%.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download